Helio Lands on Wall Street With Participation at Market Movers Investor Summit in New York

Ispire Technology Inc. Schedules Fiscal Third Quarter 2026 Earnings Conference Call

Fulgent Reports First Quarter 2026 Financial Results

Terex Reports First Quarter 2026 Results

WisdomTree Announces First Quarter 2026 Results

Assured Guaranty Ltd. Declares Quarterly Dividend of $0.38 per Common Share

Rockwell Automation Partnering with Feeding America Eastern Wisconsin and Fork Farms to Create Clock Tower Farms

HLS Therapeutics to Host Q1 2026 Financial Results Conference Call

Esperion to be Acquired by ARCHIMED

Virtus Investment Partners Announces Financial Results for First Quarter 2026

AutoNation Reports First Quarter 2026 Results

Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting

UNISYNC Corp. Reports Q2 Fiscal 2026 Results

Form 8.3 LondonMetric Property Plc & Schroder REIT Limited

Church & Dwight Reports Q1 2026 Results

Ryder Authorizes New Discretionary Plan to Repurchase Shares

Colgate Announces 1st Quarter 2026 Results

Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity

Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution

Adalimumab, Infliximab and Etanercept Biosimilars Trastuzumab Biosimilars Research Report 2026: $8.05 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035